Company Pardes Biosciences, Inc.
Equities
PRDS
US69945Q1058
Biotechnology & Medical Research
Business Summary
Number of employees: 57
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 31/12/20 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 29/08/23 |
Chief Operating Officer | - | - | |
Ann D. Kwong
CTO | Chief Tech/Sci/R&D Officer | - | - |
Patrick O’Brien
IRC | Investor Relations Contact | - | - |
Dave Kuo
HRO | Human Resources Officer | - | - |
Sean P. Brusky
PRN | Corporate Officer/Principal | 47 | 30/04/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Tananbaum
CEO | Chief Executive Officer | 60 | 31/12/20 |
Dennis Ryan
DFI | Director of Finance/CFO | 69 | 29/08/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,331,613 | 36,906,514 ( 58.28 %) | 1,319,857 ( 2.084 %) | 58.28 % |
Company contact information
Pardes Biosciences, Inc.
2173 Salk Avenue Suite 250
92008, Carlsbad
+
Sector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |